Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $2.15 Million - $2.52 Million
-10,141 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$233.58 - $259.14 $48,818 - $54,160
209 Added 2.1%
10,141 $2.47 Million
Q1 2021

May 10, 2021

BUY
$221.91 - $258.6 $471,114 - $549,007
2,123 Added 27.19%
9,932 $2.47 Million
Q4 2020

Feb 10, 2021

BUY
$216.38 - $257.67 $128,529 - $153,055
594 Added 8.23%
7,809 $1.8 Million
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $71,098 - $79,067
303 Added 4.38%
7,215 $1.83 Million
Q2 2020

Aug 13, 2020

BUY
$197.81 - $242.74 $5,340 - $6,553
27 Added 0.39%
6,912 $1.63 Million
Q1 2020

Apr 30, 2020

BUY
$182.24 - $241.7 $274,635 - $364,241
1,507 Added 28.02%
6,885 $1.4 Million
Q4 2019

Jan 31, 2020

BUY
$189.21 - $243.2 $56,006 - $71,987
296 Added 5.82%
5,378 $1.3 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $96,456 - $115,575
554 Added 12.23%
5,082 $983,000
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $104,020 - $121,935
-624 Reduced 12.11%
4,528 $834,000
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $357,424 - $402,948
1,929 Added 59.85%
5,152 $1.07 Million
Q1 2018

May 08, 2018

BUY
$169.43 - $198.0 $12,707 - $14,850
75 Added 2.38%
3,223 $549,000
Q4 2017

Feb 09, 2018

BUY
$168.79 - $188.59 $203,223 - $227,062
1,204 Added 61.93%
3,148 $547,000
Q2 2017

Aug 09, 2017

BUY
N/A
1,944
1,944 $335,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Pictet North America Advisors Sa Portfolio

Follow Pictet North America Advisors Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet North America Advisors Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet North America Advisors Sa with notifications on news.